Alpharx, Inc.

Eastgate Pharmaceuticals Inc.

Michael Weisspapir

Joseph Schwarz

The present disclosure relates to self-emulsifying pharmaceutical compositions for transmucosal delivery of biologically active peptides and proteins.

Composition for intraoral delivery of biologically active peptides and proteins

The present disclosure relates to pharmaceutical compositions of solid dosage form for intraoral administration that provides effective delivery of insulin and insulin analogs via the transmucosal route. Also provided are methods for treating pre-diabetes, diabetes and metabolic syndrome in a subject in need thereof.

Pharmaceutical composition for transmucosal delivery and methods for treating diabetes in a subject in need thereof

There is provided an ophthalmic pharmaceutical preparation comprising menthyl ester of indomethacin as an active ingredient. Also provided are different possible formulations of the ophthalmic preparation, and different methods of treating ophthalmic irritation using the ophthalmic preparation.

Ophthalmic preparation containing menthyl ester of indomethacin

A vehicle for topical delivery which contains a liquid eutectic mixture of hydrophobic compounds.

Vehicle for topical delivery of anti-inflammatory compounds

The stabilization of benzoyl peroxide for extended periods of time is disclosed. The stabilized solution contains from between 0.5% and 20% organic peroxide and a stabilizer for preventing degradation of said peroxide in the solution.

Growing community of inventors

Toronto, Canada

Michael Weisspapir